论文信息 - Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States - 字舞流文

Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States

S. Shapouri | H. Parise | M. Davids | K. Sail | Scott J Johnson | S. K. Cho | B. S. Manzoor | S. Virabhak | A. Ravelo | Tatyana Kapustyan | S. Sharmokh | B. Manzoor